Tumor vascular architecture and function evaluated by non-invasive susceptibility MRI methods and immunohistochemistry

Journal of Magnetic Resonance Imaging

Volumn 17, Issue 4, 2003, Pages 445-454

  Robinson, Simon P ^a   Rijken, Paul F J W ^b   Howe, Franklyn A ^a   McSheehy, Paul M J ^a,c   Van der Sanden, Boudewijn P J ^b,d   Heerschap, Arend ^b   Stubbs, Marion ^a   Van der Kogel, Albert J ^b   Griffiths, John R ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c NOVARTIS PHARMA AG   (Switzerland)

^d GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

BOLD MRI; Carbogen; Immunohistochemistry; Perfusion; Tumor vasculature

Indexed keywords

CARBOGEN; CONTRAST MEDIUM; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD OXYGENATION; BLOOD VESSEL DIAMETER; BLOOD VOLUME; BREATHING; CAPILLARY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; EVALUATION; FEMALE; FIBROSARCOMA; HEMATOCRIT; IMMUNOHISTOCHEMISTRY; MORPHOMETRICS; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROLACTINOMA; RAT; TUMOR VASCULARIZATION;

ANIMALS; CARBON DIOXIDE; CARCINOMA, HEPATOCELLULAR; FEMALE; FIBROSARCOMA; IMMUNOHISTOCHEMISTRY; IRON; MAGNETIC RESONANCE IMAGING; MAMMARY NEOPLASMS, ANIMAL; MICE; NEOPLASMS; OXIDES; OXYGEN; PROLACTINOMA;

EID: 12244264783     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmri.10274     Document Type: Article

References (50)

1. Ogawa S, Lee T-M, Nayak AS, Glynn P. Oxygenation-sensitive contrast in magnetic resonance image of rodent brain at high magnetic fields. Magn Reson Med 1990;14:68-78.
2. Ogawa S, Menon RS, Kim S-G, Ugurbil K. On the characteristics of functional magnetic resonance imaging of the brain. Ann Rev Biophys Biomol Struct 1998;27:447-474.
3. Boxerman JL, Hamberg LM, Rosen BR, Weisskoff RM. MR contrast due to intravascular magnetic susceptibility perturbations. Magn Reson Med 1995;34:555-566.
4. Dennie J, Mandeville JB, Boxerman JL, Packard SD, Rosen BR, Weisskoff RM. NMR imaging of changes in vascular morphology due to tumor angiogenesis. Magn Reson Med 1998;40:793-799.
5. Robinson SP, Howe FA, Rodrigues LM, Stubbs M, Griffiths JR. Magnetic resonance imaging techniques for monitoring changes in tumor oxygenation and blood flow. Semin Radiat Oncol 1998;8:197-207.
6. Al-Hallaq HA, River JN, Zamora M, Oikawa H, Karczmar GS. Correlation of magnetic resonance and oxygen microelectrode measurements of carbogen-induced changes in tumor oxygenation. Int J Radiat Oncol Biol Phys 1998;41:151-159.
7. Abramovitch R, Dafni H, Smouha E, Benjamin LE, Neeman M. In vivo prediction of vascular susceptibility to vascular endothelial growth factor withdrawal: magnetic resonance imaging of C6 rat glioma in nude mice. Cancer Res 1999;59:5012-5016.
8. Gilead A, Neeman M. Dynamic remodelling of the vascular bed precedes tumor growth: MLS ovarian carcinoma spheroids implanted in nude mice. Neoplasia 1999;1:226-230.
9. Neeman M, Dafni H, Bukhari O, Braun RD, Dewhirst MW. In vivo BOLD contrast MRI mapping of subcutaneous vascular function and maturation: validation by intravital microscopy. Magn Reson Med 2001;45:887-898.
10. Robinson SP, Howe FA, Griffiths JR. Noninvasive monitoring of carbogen-induced changes in tumor blood flow and oxygenation by functional magnetic resonance imaging. Int J Radiat Oncol Biol Phys 1995;33:855-859.
11. Robinson SP, Rodrigues LM, Ojugo ASE, McSheehy PMJ, Howe FA, Griffiths JR. The response to carbogen breathing in experimental tumour models monitored by gradient-recalled magnetic resonance imaging. Br J Cancer 1997;75:1000-1006.
12. 2* response after carbogen breathing. In: Proceedings of the 5th Annual Meeting of ISMRM, Vancouver, Canada, 1997.
13. Griffiths JR, Taylor NJ, Howe FA, et al. The response of human tumors to carbogen breathing, monitored by gradient-recalled echo magnetic resonance imaging. Int J Radiat Oncol Biol Phys 1997;39:697-701.
14. Taylor NJ, Baddeley H, Goodchild KA, et al. BOLD MRI of human tumor oxygenation during carbogen breathing. J Magn Reson Imaging 2001;14:156-163.
15. Karczmar GS, Yu C, Kuperman V, et al. Inhalation of 100% oxygen may decrease oxygenation in some tumor regions: magnetic resonance evidence for an intratumoral steal effect. In: Proceedings of the 3rd Annual Meeting of ISMRM, Nice, France, 1995.
16. Howe FA, Robinson SP, Rodrigues LM, Griffiths JR. Flow and oxygenation dependent (FLOOD) contrast MR imaging to monitor the response of rat tumours to carbogen breathing. Magn Reson Imaging 1999;17:1307-1318.
17. Troprès I, Grimault S, Vaeth A, et al. Vessel size imaging. Magn Reson Med 2001;45:397-408.
18. Howe FA, Robinson SP, McIntyre DJO, Stubbs M, Griffiths JR. Issues in flow and oxygenation dependent contrast (FLOOD) imaging of tumours. NMR Biomed 2001;14:497-506.
19. 2* and arterial blood gases. Magn Reson Imaging 2001;19:161-166.
20. Evelhoch JL. Key factors in the acquisition of contrast kinetic data for oncology. J Magn Reson Imaging 1999;10:254-259.
21. Bjornerud A, Johansson LO, Ahlstrom HK. Pre-clinical results with Clariscan (NC100150 injection): experience with different disease models. Magn Reson Mat Phys Biol Med 2001;12:99-103.
22. Turetschek K, Huber S, Floyd E, et al. MR imaging characterization of microvessels in experimental breast tumors by using a particulate contrast agent with histopathologic correlation. Radiology 2001;218:562-569.
23. 2-weighted susceptibility contrast MRI for mapping the blood volume in the glioma-bearing rat brain. Magn Reson Med 1999;42:754-761.
24. Rijken PFJW, Bernsen HJJA, van der Kogel AJ. Application of an image analysis system to the quantitation of tumor perfusion and vascularity in human glioma xenografts. Microvasc Res 1995;50:141-153.
25. Rijken PFJW, Bernsen HJJA, Peters JPW, Hodgkiss RJ, Raleigh JA, van der Kogel AJ. Spatial relationship between hypoxia and the (perfused) vascular network in a human glioma xenograft: a quantitative multi-parameter analysis. Int J Radiat Oncol Biol Phys 2000;48:571-582.
26. Twentyman PR, Brown JM, Gray JW, Franko AJ, Scoles MA, Kallman RF. A new mouse tumor model system (RIF-1) for comparison of end-point studies. J Natl Cancer Inst 1980;64:595-604.
27. 31P NMR spectra of subcutaneously implanted rat tumours. NMR Biomed 1989;1:165-170.
28. Williams JC, Gusterson B, Humphreys J, et al. N-methyl-N-nitrosourea-induced rat mammary tumors. Hormone responsiveness but lack of spontaneous metastasis. J Natl Cancer Inst 1981;66:147-155.
29. Menke H, Vaupel P. Effect of injectable or inhalational anaesthetics and of neuroleptic, neuroleptanalgesic, and sedative agents on tumor blood flow. Radiat Res 1988;114:64-76.
30. Barton SJ, Howe FA, Griffiths JR. Evidence of restriction for the slow component in a bi-exponential analysis of the apparent diffusion coefficient in RIF-1 tumors measured in vivo. In: Proceedings of the 6th Annual Meeting of ISMRM, Sydney. Australia, 1998.
31. 1H NMR spectroscopy in vivo. Magn Reson Mat Phys Biol Med 1999;8:20-26.
32. van der Sanden BPJ, in't Zandt HJ, Hoofd L, et al. Global HDO uptake in human glioma xenografts is related to the perfused capillary distribution. Magn Reson Med 1999;42:479-489.
33. Bhujwalla ZM, Artemov D, Glockner J. Tumor angiogenesis, vascularization, and contrast-enhanced magnetic resonance imaging. Top Magn Reson Imaging 1999;10:92-103.
34. Troprès I, Péoc'h M, Farion R, et al. Vessel size imaging in rat brain tumors. In: Proceedings of the 10th Annual Meeting of ISMRM, Hawaii, 2002.
35. Jain RK. Determinants of tumor blood flow: a review. Cancer Res 1988;48:2641-2658.
36. Dewhirst MW, Ong ET, Rosner GL, et al. Arteriolar oxygenation in tumour and subcutaneous arterioles: effects of inspired air oxygen content. Br J Cancer 1996;74(Suppl XXVII):S241-S246.
37. Abramovitch R, Frenkiel D, Neeman M. Analysis of subcutaneous angiogenesis by gradient echo magnetic resonance imaging. Magn Reson Med 1998;39:813-824.
38. van der Sanden BPJ, Heerschap A, Hoofd L, et al. Effect of carbogen breathing on the physiological profile of human glioma xenografts. Magn Reson Med 1999;42:490-499.
39. Liu H, Song Y, Worden KL, Jiang X, Constantinescu A, Mason RP. Noninvasive investigation of blood oxygenation dynamics of tumors by near-infrared spectroscopy. Appl Optics 2000;39:5231-5243.
40. Dunn TJ, Braun RD, Rhemus WE, et al. The effects of hyperoxic and hypercarbic gases on tumour blood flow. Br J Cancer 1999;80:117-126.
41. Robinson SP, Collingridge DR, Rodrigues LM, Howe FA, Chaplin DJ, Griffiths JR. Tumour response to hypercapnia and hyperoxia monitored by FLOOD magnetic resonance imaging. NMR Biomed 1999;12:98-106.
42. 2 using a fibre-optic oxygen sensor in rodent tumours and their response to carbogen breathing. In: Proceedings of the 6th Annual Meeting of ISMRM, Sydney, Australia, 1998.
43. Molls M, Vaupel P. Blood perfusion and microenvironment of human tumors: implications for clinical radiooncology. Berlin: Springer-Verlag; 1998.
44. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000;407:249-257.
45. Weidner N, Folkman J, Pozza F, et al. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 1992;84:1875-1887.
46. Fox SB, Leek RD, Weekes MP, Whitehouse RM, Gatter KC, Harris AL. Quantitation and prognostic value of breast cancer angiogenesis: comparison of microvessel density, Chalkley count, and computer image analysis. J Pathol 1995;177:275-283.
47. Cooper RA, Wilks DP, Logue JP, et al. High tumor angiogenesis is associated with poorer survival in carcinoma of the cervix treated with radiotherapy. Clin Cancer Res 1998;4:2795-2800.
48. Chaplin DJ, Dougherty GJ. Tumour vasculature as a target for cancer therapy. Br J Cancer 1999;80(Suppl 1):57-64.
49. Brasch RC, Li KCP, Husband JE, et al. In vivo monitoring of tumor angiogenesis with MR imaging. Acad Radiol 2000;7:812-823.
50. Gillies RJ, Bhujwalla ZM, Evelhoch JL, et al. Applications of magnetic resonance in model systems: tumor biology and physiology. Neoplasia 2000;2:139-151.